Teleflex Announces Leadership Transition

About this update from Teleflex Incorporated

[{"type":"image","alt":"Teleflex Incorporated","displaySize":"","headline":null,"caption":"Teleflex Incorporated","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":125,"url":"https://media.zenfs.com/en/globenewswire.com/b2d67c9a50caa1f1cddeda86b58ff1b8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hWX2O.eEUBx79Dv.M4CvaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3NTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b2d67c9a50caa1f1cddeda86b58ff1b8","width":300,"height":125}},"lazy":false},{"type":"text","content":"Stuart Randle Appointed Interim President and CEO","length":49,"tagName":"p"},{"type":"text","content":"Board Initiates Search for Permanent CEO","length":40,"tagName":"p"},{"type":"text","content":"Dr. Stephen Klasko Appointed Chairman of the Board","length":50,"tagName":"p"},{"type":"text","content":"Company Provides Update on Preliminary Full Year 2025 Revenue Results","length":69,"tagName":"p"},{"type":"text","content":"WAYNE, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that Stuart Randle, a member of the Company’s Board of Directors, has been appointed Interim President and Chief Executive Officer, effective immediately. Mr. Randle succeeds Liam Kelly, who departs as Chairman, President and CEO of the Company. Dr. Stephen Klasko, the Company’s Lead Director, has been named Chairman of the Board.","length":428,"tagName":"p"},{"type":"text","content":"The Board has engaged Spencer Stuart, a leading executive search firm, to assist in a comprehensive search process to identify a permanent CEO.","length":143,"tagName":"p"},{"type":"text","content":"“With the announced sale of our Acute Care, Interventional Urology and OEM businesses, Teleflex is entering its next phase as a more focused, higher-growth organization, as well as executing on the announced transactions and focusing on core critical care and high-acuity hospital markets,” said Dr. Klasko. “The Board determined this is the right time to transition leadership and best position the Company for the future. Stuart brings over 35 years of deep medical device leadership and long-standing familiarity with Teleflex as a Board member, and we are confident he will lead effectively during this period.”","length":615,"tagName":"p"},{"type":"text","content":"“I’m pleased to serve as Teleflex’s Interim CEO and wo...

More updates from Teleflex Incorporated